Cingulate Inc. Made Headway

Wed, Jul 10, 2024 at 07:12 PM

Cingulate Inc. (CING:NASDAQ) jumped higher at $0.65, representing a gain of 74.1%. On Wed, Jul 10, 2024, CING:NASDAQ touched a New 2-Week High of $0.65. The stock appeared on our News Catalysts scanner on Fri, Jun 28, 2024 at 12:03 PM in the 'PRIVATE PLACEMENT' category. From Wed, Jun 26, 2024, the stock recorded 77.78% Up Days and 60.00% Green Days

About Cingulate Inc. (CING:NASDAQ)

Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical...

Top 10 Gainers:

Kazia Therapeutics Limited (KZIA:NASDAQ), 248.02%
Inspire Veterinary Partners Inc. (IVP:NASDAQ), 110.23%
Cingulate Inc. (CING:NASDAQ), 74.05%
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 73.18%
Ampco-Pittsburgh Corporation (AP:NYSE), 60.81%
Longeveron Inc. (LGVN:NASDAQ), 58.54%
uniQure N.V. (QURE:NASDAQ), 51.72%
Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 50.83%
Phoenix New Media Limited (FENG:NYSE), 49.26%
Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 46.55%